1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA TBK1 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA APOE CTRPv2 pan-cancer AAC 0.089 0.01
mRNA COL5A1 CTRPv2 pan-cancer AAC -0.11 0.01
mRNA MARVELD3 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA APEH CTRPv2 pan-cancer AAC 0.094 0.01
mRNA ZFAND4 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA DMTN CTRPv2 pan-cancer AAC 0.088 0.01
mRNA CCL5 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA HDDC2 CTRPv2 pan-cancer AAC -0.091 0.01
mRNA BIRC5 CTRPv2 pan-cancer AAC -0.09 0.01
Download CSV